Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-05-12FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2020-05-12FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) from Cosette Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2020-05-07Clinical Trial Update: Glargine U300 Hospital Trial [Phase 4]
Phase 4 clinical trial update for Glargine U300 in hospitalized patients with Type 2 diabetes; trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-05-06Clinical Trial Update: High vs Low Dose Vitamin D in Patients With Diabetic Peripheral Neuropathy [Phase 4]
Phase 4 trial comparing high versus low dose vitamin D in patients with type 2 diabetes and diabetic neuropathy.
-
FDA approval · 2020-05-05FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approved a supplemental application for metformin hydrochloride from Westminster Pharmaceuticals, expanding/confirming the availability …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-05-05FDA Approved: FARXIGA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Farxiga (dapagliflozin) from AstraZeneca, adding/ updating labeling to reflect a new indication …
-
CLINICAL_TRIALS trial_result · 2020-05-01Clinical Trial Update: A Comparative Study of LY900014 to Insulin Lispro (Humalog) in Healthy Participants [Phase 1]
Phase 1 trial comparing LY900014 to insulin lispro (Humalog) in healthy participants; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-30Clinical Trial Update: A Study of LY900014 Formulation at Different Injection Sites in Healthy Participants [Phase 1]
Phase 1 clinical trial assessing LY900014 formulation at different injection sites in healthy participants.
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy [Phase 1]
Phase 1 trial of LY900014 in participants with type 2 diabetes on insulin therapy has completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-27Clinical Trial Update: Yo Puedo! Diabetes Self-Management Education + mHealth in Mexico City [NA]
Completed clinical trial evaluating diabetes self-management education with mobile health support for Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: A Study Comparing the Dulaglutide Pen and the Semaglutide Pen [Phase 4]
Phase 4 trial comparing the dulaglutide pen with the semaglutide pen in adults with type 2 diabetes mellitus; results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-16Clinical Trial Update: A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Diabetes and Hypertension [Phase 2]
Phase 2 trial evaluating IW-1973, a stimulator of soluble guanylate cyclase (sGC), in patients with stable type 2 diabetes and hypertension …
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 trial comparing vildagliptin+metformin versus metformin alone in treatment-naïve type 2 diabetes patients has completed, with result…
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus Patients [Phase 3]
Phase 3 trial update comparing GP40081 to NovoMix 30 FlexPen in type 2 diabetes mellitus evaluating efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: Effect of Premeal Protein-bar on Glycemic Control in Patients With Type 2 Diabetes [NA]
Clinical trial update on the effect of a premeal protein bar on glycemic control in patients with type 2 diabetes; study status completed wi…
-
CLINICAL_TRIALS trial_result · 2020-04-13Clinical Trial Update: A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems and Also to Check That MEDI0382 is Well Tolerated [Phase 2]
Phase 2 trial update evaluating MEDI0382's effect on blood sugar in type 2 diabetes with renal impairment and assessing tolerability.
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT) [Phase 3]
Phase 3 trial assessing efficacy and safety of once-weekly semaglutide added to metformin versus once-daily sitagliptin added to metformin i…
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C [Phase 2]
Phase 2 trial evaluating a fixed-dose combination of bempedoic acid and ezetimibe in patients with type 2 diabetes and elevated LDL-C has co…
-
FDA approval · 2020-04-09FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s Metformin Hydrochloride as an Original Application (ANDA) for a generic metformin hydrochloride produc…
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes [Phase 4]
Phase 4 clinical trial investigating the effect of cilostazol on carotid atherosclerosis in patients with type 2 diabetes, completed.
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Effect of Dapagliflozin on Inflammation and Endothelial Function [Phase 4]
Phase 4 trial investigating the effect of dapagliflozin on inflammation and endothelial function in type 2 diabetes mellitus; trial terminat…
-
FDA approval · 2020-04-07FDA Approved: GLIMEPIRIDE — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for glimepiride from Micro Labs Limited under an ANDA.
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: Multifactorial Treatment of Cardiovascular Risk in Diabetic Patients: Identification of Treatment Non-Responders
A completed clinical trial investigating multifactorial cardiovascular risk treatment in type 2 diabetes and identification of treatment non…
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: Assessment of Glycemic Control in Patients With Type 2 Diabetes Mellitus and Late Stage Chronic Kidney Disease [NA]
Clinical trial assessing glycemic control in type 2 diabetes patients with late-stage chronic kidney disease has completed with results post…
-
FDA approval · 2020-04-03FDA Approved: CYCLOSET — Supplemental Application (Avvisto Therapeutics LLC)
FDA approved a supplemental application for CYCLOSET (bromocriptine mesylate) submitted by Avvisto Therapeutics LLC.